Search

The haddock model of GDP KRas in complex with promazine using chemical shift perturbations and intermolecular NOEs
Authors
Wang, X., Gorfe, A.A., Putkey, J.A.
Assembly
GTPase KRas (E.C.3.6.5.2)
Entity
1. GTPase KRas (E.C.3.6.5.2), entity 1 (polymer), 169 monomers, 19245.52 Da Detail

MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL PSRTVDTKQA QDLARSYGIP FIETSAKTRQ GVDDAFYTLV REIRKHKEK


2. GTPase KRas (E.C.3.6.5.2), entity GDP (non-polymer), 443.201 Da
3. GTPase KRas (E.C.3.6.5.2), entity MG (non-polymer), 24.305 Da
4. GTPase KRas (E.C.3.6.5.2), entity P2Z (non-polymer), 284.419 Da
Total weight
19997.445 Da
Max. entity weight
19245.52 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 91.7 %, Completeness: 26.1 %, Completeness (bb): 61.6 % Detail

Polymer type: polypeptide(L)

Total1H15N
All26.1 % (316 of 1211)15.7 % (161 of 1023)82.4 % (155 of 188)
Backbone61.6 % (314 of 510)46.1 % (159 of 345)93.9 % (155 of 165)
Sidechain 0.3 % (2 of 701) 0.3 % (2 of 678) 0.0 % (0 of 23)
Aromatic 0.0 % (0 of 70) 0.0 % (0 of 70)
Methyl 0.0 % (0 of 95) 0.0 % (0 of 95)

1. entity 1

MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL PSRTVDTKQA QDLARSYGIP FIETSAKTRQ GVDDAFYTLV REIRKHKEK

Sample #1

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 7.4, Details 0.8 mM [U-99% 13C; U-99% 15N] KRAS, 1.0 mM P2Z, 5 mM [U-99% 2H] DTT, 10 uM [U-99% 2H] DSS, 25 mM sodium phosphate, 50 mM sodium chloride, 90% H2O/10% D2O


#NameIsotope labelingTypeConcentration
1KRAS[U-99% 13C; U-99% 15N]0.8 mM
2P2Znatural abundance1.0 mM
3DTT[U-99% 2H]5 mM
4DSS[U-99% 2H]10 uM
5sodium phosphatenatural abundance25 mM
6sodium chloridenatural abundance50 mM
Sample #2

Solvent system 100% D2O, Pressure 1 atm, Temperature 298 K, pH 7.4, Details 0.8 mM [U-99% 13C; U-99% 15N] KRAS, 1.0 mM P2Z, 5 mM [U-99% 2H] DTT, 10 uM [U-99% 2H] DSS, 25 mM sodium phosphate, 50 mM sodium chloride, 100% D2O


#NameIsotope labelingTypeConcentration
7KRAS[U-99% 13C; U-99% 15N]0.8 mM
8P2Znatural abundance1.0 mM
9DTT[U-99% 2H]5 mM
10DSS[U-99% 2H]10 uM
11sodium phosphatenatural abundance25 mM
12sodium chloridenatural abundance50 mM

Release date
2021-02-14
Citation
Antipsychotic phenothiazine drugs bind to KRAS in vitro
Wang, X., Gorfe, A.A., Putkey, J.A.
J. Biomol. NMR (2021), 75, 233-244, PubMed 34176062 , DOI 10.1007/s10858-021-00371-z ,
Related entities 1. GTPase KRas (E.C.3.6.5.2), entity 1, : 1 : 24 : 5 : 74 : 195 entities Detail
Interaction partners 1. GTPase KRas (E.C.3.6.5.2), entity 1, : 53 interactors Detail
Experiments performed 10 experiments Detail
Chemical shift validation 6 contents Detail
Keywords CHEMICAL SHIFT CHANGES, GDP KRAS, HADDOCK STRUCTURE MODEL, HYDROLASE, INTERMOLECULAR NOE, SMALL MOLECULE LIGAND